الفهرس 
INTRODUCTIONOnly 14 pages are availabe for public view
 |  | from | 152 |  |  |
| | | from | 152 | | |
Abstract
Aim of the work
The aim of this work is to study the prevalence of HCV antibodies in patients with NAFL; to study the factors helping to predict the presence of HCV antibodies in patients with NAFL and to study the possibility of HCV as a cause or as a risk factor of nonalcoholic fatty liver disease (NAFL) distinct from other causes of steatosis.
Conclusion
1- The prevalence of HCV antibodies in patients with NAFL (49%) is higher than that in the general population.
2- The factors helping to predict the presence of HCV antibodies in patients with NAFL are high AST level, old age and low BMI.
3- HCV can be listed as a cause or as a risk for NAFLD distinct from other causes of steatosis in Egypt.
4- HCV infection increased with age in general population.
5- HCV infection has negative effect on the serum cholesterol level and this may be related in some extent to the pathogenesis of fatty liver.